Hepatocyte growth factor is required for alveologenesis in the neonatal rat

被引:46
作者
Padela, S
Cabacungan, J
Shek, S
Belcastro, R
Yi, M
Jankov, RP
Tanswell, AK
机构
[1] Hosp Sick Children, Sunnybrook & Womens Res Inst, Canadian Inst Hlth Res Grp Lung Dev, Lung Biol Programme,Res Inst, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A1, Canada
基金
加拿大健康研究院;
关键词
bronchopulmonary dysplasia; lung growth; lung injury; morphometry; soluble receptors;
D O I
10.1164/rccm.200504-567OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Our core hypothesis is that growth factors that have dysregulated expression during experimental neonatal lung injury are likely to be involved in normal postnatal lung growth and alveologenesis. Objectives:To determine if hepatocyte growth factor (HGF) is upregulated in neonatal lung injury and is essential for postnatal alveologenesis. Methods: A neonatal lung injury, in which there were patchy areas of interstitial thickening with a relative increase in the proportion of epithelial cells, was induced in newborn rats by exposing them to 60% oxygen for 14 days. Air-exposed pups had binding of endogenous HGF to its natural receptor, c-Met, inhibited by the intraperitoneal injection of either neutralizing antibody to HGF, or a truncated soluble c-Met receptor. Measurements and Main Results: The 60% oxygen-mediated lung injury was associated with increased lung mRNAs for hepatocyte growth factor and c-Met, relative to air-exposed control lungs, at Day 7 after birth. After exposure to 60% oxygen, immunoreactive HGF was increased at Days 4 and 7, and immunoreactive c-Met was increased at Day 14. In air-exposed pups, intraperitoneal injections of neutralizing antibody to HGF inhibited DNA synthesis in alveoli-forming secondary crests, and reduced the number of alveoli in 6-day-old pups. Intraperitoneal injections of a truncated soluble c-Met receptor inhibited DNA synthesis in secondary crests in 4-day-old air-exposed rat pups. Conclusions: HGF and its c-Met receptor are required for normal postnatal alveolar formation from secondary crests, and are upregulated during 60% oxygen-induced neonatal lung injury.
引用
收藏
页码:907 / 914
页数:8
相关论文
共 50 条
[1]   Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin [J].
Adamson, IYR ;
Bakowska, J .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) :949-954
[2]  
[Anonymous], CHRONIC LUNG DIS EAR
[3]   BRONCHOPULMONARY DYSPLASIA - PULMONARY PATHOLOGIC SEQUEL OF NECROTIZING BRONCHIOLITIS AND PULMONARY FIBROSIS [J].
BONIKOS, DS ;
BENSCH, KG ;
NORTHWAY, WH ;
EDWARDS, DK .
HUMAN PATHOLOGY, 1976, 7 (06) :643-666
[4]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Changes in expression of platelet-derived growth factor and its receptors in the lungs of newborn rats exposed to air or 60% O2 [J].
Buch, S ;
Han, RNN ;
Cabacungan, J ;
Wang, JX ;
Yuan, SZ ;
Belcastro, R ;
Deimling, J ;
Jankov, R ;
Luo, XP ;
Lye, SJ ;
Post, M ;
Tanswell, AK .
PEDIATRIC RESEARCH, 2000, 48 (04) :423-433
[7]  
Burri PH, 1997, LUNG GROWTH DEV, P1
[8]   HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641
[9]   A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia [J].
Chang, LYL ;
Subramaniam, M ;
Yoder, BA ;
Day, BJ ;
Ellison, MC ;
Sunday, ME ;
Crapo, JD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (01) :57-64
[10]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2